JD Health International (HKSE:06618) Accounts Receivable : HK$612 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is JD Health International Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. JD Health International's accounts receivables for the quarter that ended in Dec. 2023 was HK$612 Mil.

Accounts receivable can be measured by Days Sales Outstanding. JD Health International's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 3.87.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. JD Health International's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$9.78.

JD Health International Accounts Receivable Historical Data

The historical data trend for JD Health International's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International Accounts Receivable Chart

JD Health International Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

Get a 7-Day Free Trial

23.18

94.40

464.10

884.27

612.13

JD Health International Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Receivable	Get a 7-Day Free Trial							464.10	883.83	884.27	385.76	612.13

JD Health International Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

JD Health International Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

JD Health International's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	612.126	/	28897.206	*	91
=	3.87

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), JD Health International's accounts receivable are only considered to be worth 75% of book value:

JD Health International's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(44285.36	+	0.75 * 612.126	+	0.5 * 5561.4	-	16317.033
-	0	-	15.873)	/	3188.61
=	9.78

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

JD Health International Accounts Receivable Related Terms

Thank you for viewing the detailed overview of JD Health International's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (HKSE:06618) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

JDHIY:USA JDHIF:USA 8ZN:Germany

Address

No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111

Website

https://ir.jdhealth.com

JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (HKSE:06618) Headlines

No Headlines